Ethics statement
The Institutional Review Board of Christian Medical College Vellore (10392 [INTERVEN]), and the Human Subjects Division at the University of Washington (STUDY00000180) approved the DeWorm3 trial in India. The trial is registered at ClinicalTrials.gov (NCT03014167). The CMC IRB approved this study as an amendment (IRB–A4, September 26, 2018). Written informed consent was obtained from all who participated in the study.